Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOGO, KLIC, SYMC, HAIR, and FLKS

KLIC, SLRX, FLEX, PCG, NWL, PRTA, REVG, ESPR, ORA, FLR

NEW YORK, July 06, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm reminds investors that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Gogo Inc. (NASDAQ:GOGO)
Lead Plaintiff Deadline: August 27, 2018
Class Period: February 27, 2017 - May 7, 2018

Allegations: Gogo’s 2Ku antenna had more reliability issues than the public was led to believe; Gogo’s 2Ku antennas required costly installation and faced costly remediation challenges or required replacement due to deicing fluids from planes infiltrating the 2Ku system, as well as manufacturing and software issues; consequently, Gogo would not be able to meet its previously issued 2018 guidance; and as a result, the company’s financial statements were materially false and misleading at all relevant times.

Get additional information: http://www.kleinstocklaw.com/pslra-c/gogo-inc?wire=3.

Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC)
Lead Plaintiff Deadline: July 10, 2018
Class Period: November 16, 2017 - May 10, 2018

Allegations: Kulicke and Soffa Industries, Inc.’s consolidated financial statements for the fiscal year ending September 30, 2017 could no longer be relied upon due to misstated warranty accruals; and as a result, Defendants' public statements were materially false and misleading at all relevant times.

Get additional information: http://www.kleinstocklaw.com/pslra-c/kulicke-and-soffa-industries-inc-2?wire=3.

Symantec Corp. (NASDAQ:SYMC)
Lead Plaintiff Deadline: July 16, 2018
Class Period: May 20, 2017 - May 10, 2018

Allegations: Symantec's internal controls over financial reporting were materially weak and deficient; Symantec's later disclosed "reporting of certain Non-GAAP measures including those that could impact executive compensation programs" would lead to heightened regulatory scrutiny by the SEC; and as a result, Symantec's public statements were materially false and misleading at all relevant times.

Get additional information: http://www.kleinstocklaw.com/pslra-c/symantec?wire=3.

Restoration Robotics, Inc. (NASDAQGM:HAIR)
Lead Plaintiff Deadline: August 21, 2018
Class Period: purchased shares pursuant and/or traceable to the Company’s Initial Public Offering between October 12, 2017 and October 16, 2017

Allegations: The complaint alleges that Restoration Robotics negligently issued untrue statements of material facts in, and omitted to state material facts required to be stated from, the Offering Materials issued in connection with the Initial Public Offering. The complaint further alleges that as a result of the materially misleading Offering Materials, the Company’s stock price was artificially inflated at the time of the IPO.

Get additional information: http://www.kleinstocklaw.com/pslra-c/restoration-robotics-inc-hair?wire=3.

Flex Pharma, Inc. (NASDAQ:FLKS)
Lead Plaintiff Deadline: August 20, 2018
Class Period: November 6, 2017 - June 12, 2018

Allegations: The Company overstated the viability and approval prospects for its product candidate FLX-787 for the treatment of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease; and as a result, Flex Pharma's public statements were materially false and misleading at all relevant times.

Get additional information: http://www.kleinstocklaw.com/pslra-c/flex-pharma-inc?wire=3.

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
                                                            
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com 
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com 

Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today